Pseudomonas aeruginosa in hospitalized patients with infective exacerbations of bronchiectasis: Clinical and research implications

Annals of Saudi Medicine

Volumn 18, Issue 5, 1998, Pages 469-471

  Al Mobeireek, Abdullah ^a,c   Kambal, Abdul Majeed ^a   Al Balla, Saleh R ^a   Al Sawwaf, Hassan ^b   Saleemi, Sarfaz ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b Sahary Chest Hospital   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN;

ACINETOBACTER; ADULT; AGED; ARTICLE; BACTERIOLOGY; BRONCHIECTASIS; BRONCHUS SECRETION; CLINICAL FEATURE; DISEASE SEVERITY; ENTEROBACTER CLOACAE; FEMALE; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SAUDI ARABIA; SCHOOL CHILD; SPUTUM ANALYSIS; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS;

EID: 0032424730     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1998.469     Document Type: Article

References (18)

1. Saynajakangas O, Keistinen T, Tuuponen T, Kivela SL. Bronchiectasis in Finland: trends in hospital treatment. Respir Med 1997;91:395-8.
2. Nicotra MB. Bronchiectasis. Semin Respir Infec 1994;9:31-40.
3. Evans SA, Turner SM, Bosch BJ, Hardy CC, Woodhead MA. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J 1996;9:1601-4.
4. Pang JA, Cheng A, Chan HS, Poon D, French G. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am Rev Respir Dis 1989;139:14-7.
5. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995;108:955-61.
6. Nazer H, Riff E, Sakati N, Matthew R, Majeed-Saidan MA, Harfi H. Cystic fibrosis in Saudi Arabia. Eur J Pediatr 1989;148:330-2.
7. Shishido H, Nagai H, Kurashima A, et al. Tuberculosis sequelae: secondary bacterial infections. Kekkaku 1990;65:873-80.
8. Cole P, Wilson R. Host-microbial interrelationships in respiratory infection. Chest 1989;95:217S-21S.
9. Rivera M, Nicotra MB. Pseudomonas aeruginosa mucoid strain: its significance in adult chest disease. Am Rev Respir Dis 1982;126:833-6.
10. Miszkiel KA, Wells AU, Rubens MB, Cole PJ, Hansell DM. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study. Thorax 1997;52:260-4.
11. Nagaki M, Shimura S, Tanno Y, Ishibashi T, Sasaki H, Takishima T. Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis. Chest 1992;102:1464-9.
12. Tabbara KF, Frayha H. The use and abuse of antibiotics. Ann Saudi Med (editorial) 1996;16:495-6.
13. Rayner CFJ, Tillotson G, Cole PJ, Wilson R. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemo 1994;34:149-56.
14. Lam WK, Chau PY, So SY, Leung YK, Chan CK, Ip M, et al. Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis. Respir Med 1989;83:299-303.
15. Ashour M, Al-Kattan KM, Jain SK, Al-Majid S, Al-Kassimi F, Mobaireek A, et al. Surgery for unilateral bronchiectasis: results and prognostic factors. Tuber Lung Dis 1996;77:168-72.
16. Ramsey BW, Wentz KR, Smith AL, et al. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis 1991;144:331-7.
17. Thomassen MJ, Klinger JD, Badger SJ, van Heeckeren DW, Stern RC. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. J Pediatr 1984;104:352-6.
18. World Health Organization. Chronic cor pulmonale: a report of the expert committee. Circulation 1963;27:594-615.